Las Vegas Sands Corp. (BIT:1LVS)

Market Cap	31.69B
Revenue (ttm)	9.89B
Net Income (ttm)	1.20B
Shares Out	n/a
EPS (ttm)	1.68
PE Ratio	26.36
Forward PE	20.91
Dividend	0.89 (1.95%)
Ex-Dividend Date	Aug 4, 2025

Volume	n/a
Average Volume	7
Open	45.58
Previous Close	45.58
Day's Range	45.58 - 45.58
52-Week Range	35.37 - 46.44
Beta	n/a
RSI	75.88
Earnings Date	Jul 23, 2025

About Ligand Pharmaceuticals

Las Vegas Sands Corp., together with its subsidiaries, owns, develops, and operates integrated resorts in Macao and Singapore. The company owns and operates The Venetian Macao Resort Hotel, The Londoner Macao, The Parisian Macao, The Plaza Macao and Four Seasons Hotel Macao, and The Sands Macao in Macao, the People’s Republic of China; and Marina Bay Sands in Singapore. Its integrated resorts feature accommodations, gaming, entertainment and retail malls, convention and exhibition facilities, celebrity chef restaurants, and other amenities. The...

• Industry: Miscellaneous Amusement And Recreation
• Founded: 1988
• Employees: 40,300
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1LVS

Financial Performance

In 2024, Las Vegas Sands's revenue was $11.30 billion, an increase of 8.93% compared to the previous year's $10.37 billion. Earnings were $1.45 billion, an increase of 18.43%.